Cisplatin concurrent chemoradiotherapy vs adjuvant radiation in stage IB/IIA cervical cancer with intermediate risk factors, treated with radical surgery: a retrospective study

Cisplatin concurrent chemoradiotherapy vs adjuvant radiation in stage IB/IIA cervical cancer with intermediate risk factors, treated with radical surgery: a retrospective study

Hai-Yan Sun, Qiu Tang, Jian-Hong Chen, Xiao-Juan Lv, Ye-Qiang Tu, Ding-Ding Yan Department of Gynecologic Oncology, Zhejiang Cancer Hospital, Hangzhou, China Purpose: To determine if postoperative cisplatin concurrent chemoradiotherapy (CCRT) improves the outcome in stage IA/IIB cervical cancer pati...

Full description

Bibliographic Details
Main Authors: Sun H, Tang Q, Chen J, Lv X, Tu Y, Yan D
Format: Article
Language:English
Published: Dove Medical Press 2018-03-01
Series:OncoTargets and Therapy
Subjects:
Cervical cancer
concurrent chemoradiotherapy
intermediate risk factors
Online Access:https://www.dovepress.com/cisplatin-concurrent-chemoradiotherapy-vs-adjuvant-radiation-in-stage--peer-reviewed-article-OTT

Internet

https://www.dovepress.com/cisplatin-concurrent-chemoradiotherapy-vs-adjuvant-radiation-in-stage--peer-reviewed-article-OTT

Similar Items